KARLIN DANIEL (Chief Medical Officer) sold 1.9% of their position (8.02K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $148.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/26/2026ACC: 0001193125-26-126830
Officer· Chief Medical Officer
Since Jan 2022
-8.02K
Net shares
Net seller
$148.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.02K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−8.02K
Price / share
$18.47
Trade value
$148.09K
% of position
1.9%
3/25/2026
421.33K→413.32K
Total
Net shares
−8.02K
Net value
-$148.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/25/2026 | S · Sale | −8.02K | $18.47 | $148.09K | 1.9% | 421.33K | 413.32K |
| Total | −8.02K | -$148.09K | ||||||
Derivative Transactions0
No derivative transactions reported